{{COI|date=February 2017}}
{{refimprove|date=February 2017}}
{{Infobox company
|name     = AryoGen
|logo             = [[File:AryoGen Biopharma Logo.png]]
|type             = [[Private Company]]
|area_served      = Worldwide
|key_people       = Dr. Fereidoun Mahboudi<br/>[[Chairman]]
|industry         = [[Pharmaceutical industry|Pharmaceutical]]
|products         = [[biopharmaceutical]]s, [[Monoclonal antibody]]
|revenue          = {{Increase}} US$ 100 [[1000000 (number)|million]]
|operating_income = 
|net_income       = 
|assets           = 
|equity           = 
|num_employees    = {{Increase}} 300+ (2015)
|divisions        =
|subsid           = 
|slogan   = 
|
|foundation       = 2009
|location_city    = [[Tehran]]
|location_country = [[Iran]]
|homepage         = [http://www.aryogen.com/ AryoGen ]
}}
'''AryoGen Pharmed''' (in Persian: آریوژن فارمد ) is an [[Iran]]ian biopharmaceutical company specializing in manufacturing Therapeutic [[Monoclonal antibodies]] and some other [[recombinant proteins]].<ref>{{cite web |url=http://www.highbeam.com/doc/1G1-279301420.html |title=IRAN, ISLAMIC REPUBLIC OF : Aryogen produces locally made medicines in Iran; helps Iran save up to $100 mln annually. |work=[[Mena Report]]}}</ref><ref>[http://www.highbeam.com/doc/1G1-279167049.html World's 2nd factor VII factory opened in Iran. - Mehr News Agency (MNA) | HighBeam Research<!-- Bot generated title -->]</ref><ref>[http://en.trend.az/regions/iran/1988517.html Iran launches domestic manufacture of anti-hemophilia drug - Trend.Az<!-- Bot generated title -->]</ref>

==History==
AryoGen is a biopharmaceutical company created on the mandate of Iranian executive branch. It was created a group of scientific experts spun off a well versed [[Biopharmaceutical]] company, which formed a totally new entity christened as AryoGen Biopharma which started its production in 2011. It was deemed an issue of national interest due to the importance of the target products on Iran's community health care system, as well as its impact in the region and around the world. 

AryoGen is the world's first company to produce biosimilar Blood [[Coagulation]] Factor VII, which required a 50 million Euros product investment. Also AryoGen has established a monoclonal antibodies production line amongst only 10 manufacturer of the world.  

AryoGen has changed his name to AryoGen Pharmed since 2016.   
[[File:inside Aryogen.jpg|thumb|alt=Inside Aryogen, production line for AryoSeven|Inside Aryogen, production line for AryoSeven]]

== Products ==
AryoGen's products include:
* Blood [[Coagulation]] factor VII with the name of '''[[AryoSeven]]''' which is a biosimilar form of Novoseven with multi billion dollars world market and is used for hemophilia patients and other conditions
* '''Altebrel''' with the generic name of [[Etanercept]] and original trade name of Enbrel which for some years was the no. one in the biopharmaceutical market and is used for treatment of autoimmune diseases
* '''Zytux''' with the generic name of [[Rituximab]] and original trade name of Rituxan which is an anticancer biomedicine,
* '''َAryoTrust''' with the generic name of [[trastuzumab]] and original name of Herceptin which is a revolutionary drug in treatment of breast cancer
* '''Stivant''' with the generic name of [[bevacizumab]] and original trade name of Avestin and is used for treatment of some sort of cancer.
[[AryoSeven]] is now approved by Iranian food and drug organisation and from Aug 2012 is in the market and other biomedicines are closing to the market.
{{wide image|AryoGen Biopharma Complex panorama.jpg|1100px|alt= 22000 sqm AryoGen Biopharma complex in a panorama photo|align-cap=center|AryoGen Pharmed Complex.}}

==See also==
*[[Healthcare in Iran]]

==References==
<references/>

==External links==
* [https://web.archive.org/web/20120807101710/http://www.aryogen.com/ AryoGen - Home]
* [http://bleedingdisorder.wordpress.com/tag/hemophilia-b/ Hemophilia]
* [https://web.archive.org/web/20130312083335/http://www.list-of-companies.org/Iran/Keywords/pharmaceutical/ List of biopharmaceutical companies]
* [http://en.trend.az/regions/iran/1988517.html/ Launching domestic manufacture of anti-hemophilia drug]
* [http://www.irct.ir/searchresult.php?id=6302&number=1/ Related Clinical trials]

[[Category:Biopharmaceutical companies]]
[[Category:Pharmaceutical companies of Iran]]
[[Category:Pharmaceutical companies established in 2009]]